Relationship between flow-mediated vasodilation and cardiovascular risk factors in a large community-based study

Heart

Volumn 99, Issue 24, 2013, Pages 1837-1842

  Maruhashi, Tatsuya ^a   Soga, Junko ^a   Fujimura, Noritaka ^a   Idei, Naomi ^a   Mikami, Shinsuke ^a   Iwamoto, Yumiko ^a   Kajikawa, Masato ^a   Matsumoto, Takeshi ^a   Hidaka, Takayuki ^a   Kihara, Yasuki ^a   Chayama, Kazuaki ^a   Noma, Kensuke ^b,c   Nakashima, Ayumu ^c   Goto, Chikara ^d   Tomiyama, Hirofumi ^e   Takase, Bonpei ^f   Yamashina, Akira ^e   Higashi, Yukihito ^b,c  

^a HIROSHIMA UNIVERSITY   (Japan)

^b HIROSHIMA UNIVERSITY   (Japan)

^c HIROSHIMA UNIVERSITY HOSPITAL   (Japan)

^d HIROSHIMA INTERNATIONAL UNIVERSITY   (Japan)

^e TOKYO MEDICAL UNIVERSITY   (Japan)

^f NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADOLESCENT; ADULT; AGE; AGED; ARTERY DIAMETER; ARTICLE; ATHEROSCLEROSIS; BODY MASS; BRACHIAL ARTERY; CARDIOVASCULAR RISK; CEREBROVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; CROSS-SECTIONAL STUDY; DIASTOLIC BLOOD PRESSURE; FEMALE; FLOW MEDIATED VASODILATION; FRAMINGHAM RISK SCORE; HUMAN; ISCHEMIC HEART DISEASE; JAPAN; MALE; PREVALENCE; PRIORITY JOURNAL; SEX DIFFERENCE; SMOKING; SYSTOLIC BLOOD PRESSURE; VASODILATATION;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; BLOOD FLOW VELOCITY; BODY MASS INDEX; BRACHIAL ARTERY; CARDIOVASCULAR DISEASES; CROSS-SECTIONAL STUDIES; ELECTROCARDIOGRAPHY; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; JAPAN; MALE; MIDDLE AGED; MORBIDITY; PROGNOSIS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SEX DISTRIBUTION; VASODILATION; YOUNG ADULT;

EID: 84888033952     PISSN: 13556037     EISSN: 1468201X     Source Type: Journal    
DOI: 10.1136/heartjnl-2013-304739     Document Type: Article

References (30)

1. Ross R. Atherosclerosis - an in flammatory disease. N Engl J Med 1999;340:115-26.
2. Lerman A, Zeiher AM. Endothelial function: cardiac events. Circulation 2005;111:363-8.
3. Celermajer DS, Sorensen KE, Gooch VM, et al. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet 1992;340:1111-15.
4. Celermajer DS, Sorensen KE, Bull C, et al. Endothelium-dependent dilation in the systemic arteries of asymptomatic subjects relates to coronary risk factors and their interaction. J Am Coll Cardiol 1994;24:1468-74.
5. Benjamin EJ, Larson MG, Keyes MJ, et al. Clinical correlates and heritability of flow-mediated dilation in the community: the Framingham Heart Study. Circulation 2004;109:613-19.
6. Idei N, Nishioka K, Soga J, et al. Vascular function and circulating progenitor cells in thromboangitis obliterans (Buerger's disease) and atherosclerosis obliterans. Hypertension 2011;57:70-8.
7. Soga J, Noma K, Hata T, et al. Rho-associated kinase activity, endothelial function, and cardiovascular risk factors. Arterioscler Thromb Vasc Biol 2011;31:2353-9.
8. Modena MG, Bonetti L, Coppi F, et al. Prognostic role of reversible endothelial dysfunction in hypertensive postmenopausal women. J Am Coll Cardiol 2002;40:505-10.
9. Gokce N, Keaney JF Jr., Hunter LM, et al. Risk stratification for postoperative cardiovascular events via noninvasive assessment of endothelial function: a prospective study. Circulation 2002;105:1567-72.
10. Yeboah J, Folsom AR, Burke GL, et al . Predictive value of brachial flow-mediated dilation for incident cardiovascular events in a population-based study: the multi-ethnic study of atherosclerosis. Circulation 2009;120:502-9.
11. Corretti MC, Anderson TJ, Benjamin EJ, et al. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol 2002;39:257-65.
12. Inoue T, Matsuoka H, Higashi Y, et al. Flow-mediated vasodilation as a diagnostic modality for vascular failure. Hypertens Res 2008;31:2105-13.
13. Celermajer DS, Sorensen KE, Spiegelhalter DJ, et al. Aging is associated with endothelial dysfunction in healthy men years before the age-related decline in women. J Am Coll Cardiol 1994;24:471-6.
14. Wisloff U, Stoylen A, Loennechen JP, et al. Superior cardiovascular effect of aerobic interval training versus moderate continuous training in heart failure patients: a randomized study. Circulation 2007;115:3086-94.
15. Black MA, Cable NT, Thijssen DH, et al. Importance of measuring the time course of flow-mediated dilatation in humans. Hypertension 2008;51:203-10.
16. Schroeder S, Enderle MD, Baumbach A, et al. Influence of vessel size, age and body mass index on the flow-mediated dilatation (FMD%) of the brachial artery. Int J Cardiol 2000;76:219-25.
17. Expert committee on the diagnosis and classification of diabetes mellitus, American Diabetes Association: clinical practice recommendations 1999. Diabetes Care 1999;22(Suppl 1):S1-114.
18. Expert panel on detection, evaluation and treatment of high blood cholesterol in adults. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). JAMA 2001;285:2486-97.
19. Wilson PW, Castelli WP, Kannel WB. Coronary risk prediction in adults (the Framingham Heart Study). Am J Cardiol 1987;59:91G-4G.
20. Chobanian AV, Barkis GL, Black HR et al. The seventh report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Arch Intern Med 2003;289:2560-72.
21. Herrington DM, Fan L, Drum M, et al. Brachial flow-mediated vasodilator responses in population-based research: methods, reproducibility and effects of age, gender and baseline diameter. J Cardiovasc Risk 2001;8:319-28.
22. Higashi Y, Sasaki S, Nakagawa K, et al. Tetrahydrobiopterin improves aging-related impairment of endothelium-dependent vasodilation through increase in nitric oxide production. Atherosclerosis 2006;186:390-5.
23. Dohi Y, Thiel MA, Buhler FR, et al. Activation of endothelial L-arginine pathway in resistance arteries. Effect of age and hypertension. Hypertension 1990;16:170-9.
24. Panza JA, Casino PR, Kilcoyne CM, et al. Role of endothelium-derived nitric oxide in the abnormal endothelium-dependent vascular relaxation of patients with essential hypertension. Circulation 1993;87:1468-74.
25. Huang PL, Huang Z, Mashimo H, et al. Hypertension in mice lacking the gene for endothelial nitric oxide synthase. Nature 1995;377:239-42.
26. Higashi Y, Sasaki S, Nakagawa K, et al. Endothelial function and oxidative stress in renovascular hypertension. N Engl J Med 2002;346:1954-62.
27. Brasier AR, Recinos A III, Eledrisi MS. Vascular inflammation and the renin-angiotensin system. Arterioscler Thromb Vasc Biol 2002;22:1257-66.
28. Vasan RS, Larson MG, Leip EP, et al. Impact of high-normal blood pressure on the risk of cardiovascular disease. N Engl J Med 2001;345:1291-7.
29. Silber HA, Bluemke DA, Ouyang P, et al. The relationship between vascular wall shear stress and flow-mediated dilation: endothelial function assessed by phase-contrast magnetic resonance angiography. J Am Coll Cardiol 2001;38:1859-65.
30. Silber HA, Ouyang P, Bluemke DA, et al. Why is flow-mediated dilation dependent on arterial size? Assessment of the shear stimulus using phase-contrast magnetic resonance imaging. Am J Physiol Heart Circ Physiol 2005;288:H822-8.